Lv5
1020 积分 2023-07-24 加入
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel
6天前
已关闭
Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials
6天前
已完结
Cyclosporin A up-regulated thromboxane A2 receptor through activation of MAPK and NF-κB pathways in rat mesenteric artery
18天前
已关闭
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel
19天前
已关闭
American Academy of Dermatology Annual Meeting: Orlando, FL, USA, 7-11 March 2025
19天前
已完结
Selective Tyrosine Kinase 2 (TYK2) Inhibition in Plaque Psoriasis
19天前
已完结
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
19天前
已完结
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway
19天前
已完结
Cyclosporin A up-regulated thromboxane A2 receptor through activation of MAPK and NF-κB pathways in rat mesenteric artery
19天前
已关闭
Characteristics of pruritus in various clinical variants of psoriasis: Final report of the binational, multicentre, cross‐sectional study
19天前
已完结
皖公网安备34019202002308
